Clinical trials
Completed Obesity trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2009 | 2 |
| 2012 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 11 |
| 2024 | 8 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 13 |
| Eli Lilly and Company | 8 |
| AstraZeneca | 6 |
| Boehringer Ingelheim | 4 |
| Hiroshima University | 3 |
| Amgen | 1 |
| Bispebjerg Hospital | 1 |
| Eisai Limited | 1 |
| Japanese Plasmalogen Society | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 42 |
| Overweight | 20 |
| Diabetes Mellitus, Type 2 | 7 |
| Nutrition Disorders | 5 |
| Weight Loss | 3 |
| Hypertension | 1 |
| Malnutrition | 1 |
| Metabolic Diseases | 1 |
| Metabolic Syndrome | 1 |
| Prediabetic State | 1 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.